//
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Vaccination Trends in Patients With Heart Failure - Insights From Get With The Guidelines–Heart Failure
Lateral Wall Dysfunction Signals Onset of Progressive Heart Failure in Left Bundle Branch Block
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction
Ejection Fraction Pros and Cons: JACC State-of-the-Art Review